CRISPR Therapeutics AG
COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A

Last updated:

Abstract:

Provided include materials and methods for treating Hemophilia A in a subject ex vivo or in vivo. Also provided include materials and methods for knocking in a FVIII-encoding gene in a genome, in particular the locus of albumin gene.

Status:
Application
Type:

Utility

Filling date:

17 Oct 2018

Issue date:

17 Mar 2022